KLP Kapitalforvaltning AS Buys Shares of 4,600 ICU Medical, Inc. (NASDAQ:ICUI)

KLP Kapitalforvaltning AS bought a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund bought 4,600 shares of the medical instruments supplier's stock, valued at approximately $714,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Harvest Fund Management Co. Ltd purchased a new stake in ICU Medical in the fourth quarter worth $33,000. Point72 Hong Kong Ltd bought a new position in shares of ICU Medical during the 3rd quarter worth $72,000. Venturi Wealth Management LLC increased its holdings in ICU Medical by 64.0% in the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after acquiring an additional 206 shares during the last quarter. Smartleaf Asset Management LLC raised its stake in ICU Medical by 166.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock valued at $140,000 after acquiring an additional 567 shares during the period. Finally, Coldstream Capital Management Inc. purchased a new stake in ICU Medical during the third quarter valued at about $227,000. 96.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on ICUI. Raymond James set a $97.00 price target on shares of ICU Medical in a research report on Wednesday, March 12th. StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Friday. Finally, Jefferies Financial Group raised ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target for the company in a report on Wednesday, December 11th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, ICU Medical currently has an average rating of "Buy" and a consensus price target of $168.67.

Remove Ads

ICU Medical Price Performance

Shares of ICUI traded down $2.25 during mid-day trading on Friday, reaching $139.32. 597,700 shares of the stock traded hands, compared to its average volume of 265,684. The company has a market cap of $3.42 billion, a price-to-earnings ratio of -30.49 and a beta of 0.86. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26. The firm has a fifty day moving average price of $151.64 and a 200 day moving average price of $162.46. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.